Role of GPER1 in the Mechanism of EGFR-TKIs Resistance in Lung Adenocarcinoma

Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have a good clinical efficacy in lung adenocarcinoma harboring activating-mutation EGFR. Such EGFR mutations are more frequently observed in women and non-smokers. EGFR mutations are frequently reported to correlate with estro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenhua, Pan, Yaqiang, Liu, Qinghua, Wang, Jian, Liu, Chang, Qu, Laihao, Li, Dingbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158128/
https://www.ncbi.nlm.nih.gov/pubmed/35664735
http://dx.doi.org/10.3389/fonc.2022.869113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158128/
https://www.ncbi.nlm.nih.gov/pubmed/35664735
http://dx.doi.org/10.3389/fonc.2022.869113

Ejemplares similares